Industry’s concerns remain unaddressed – a missed opportunity, says association CEO.

Immune disorders and diabetes remain top conditions for drug spending in 2023.

Patented Medicine Prices Review Board looks at Canadian sales of new medicines.

The Canadian Life & Health Insurance Association says Bill C-64 must be read in its entirety to understand the implicati…

Canadian Life & Health Insurance Association provides primer on long-term illness leave to Ontario ministry.

Reinsurer urges companies not to shy away from pursuing legal action where possible.

Clients also given access to care program that includes one-on-one health support.